bioAffinity Technologies, Inc.: documents
17 reports and filings since Apr 30, 2026, each linked to the copy the company filed with the regulator.
Quarterly reports#
3 on file.
- Nov 6, 202610-QQuarterly report, period to 30 September 2026all files
- Aug 7, 202610-QQuarterly report, period to 30 June 2026all files
- May 11, 202610-QQuarterly report, period to 31 March 2026all files
Results announcements#
3 on file.
Proxy statements#
1 on file.
- Oct 23, 2026DEF 14AProxy statement, period to 23 October 2026all files
Other current reports#
6 on file.
- Oct 9, 20268-KMaterial agreement; Unregistered share saleall files
- Aug 20, 20268-KShareholder rights changed; Bylaws or fiscal year changedall files
- Aug 14, 20268-KMaterial agreement; Unregistered share saleall files
- Jul 31, 20268-KDelisting noticeall files
- Jun 18, 20268-KMaterial agreementall files
- Apr 30, 20268-KDirectors and officers; Shareholder voteall files
Registration statements and prospectuses#
4 on file.
- Jun 18, 2026424B4Final prospectusall files
- Jun 16, 2026S-1/ARegistration statement, amendedall files
- Jun 12, 2026S-1Registration statementall files
- Apr 30, 2026S-1Registration statementall files
Source: SEC EDGAR filings and ESEF annual reports (filings.xbrl.org). Results announcements are 8-K filings with item 2.02: the press release is one of the filing's exhibits, under "all files". Every filing of the company is on EDGAR. The figures read from these reports